Press Releases
Recipharm and Altus Formulation collaborate to offer novel drug delivery technologies for value added medicines
Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug development company, to allow its...
Press Releases
Lilly’s Verzenio for Advanced Breast Cancer Receives Additional FDA Approval
Eli Lilly and Company announced that the U.S. FDA has approved Verzenio™ in combination with an aromatase inhibitor (AI) as initial endocrine-based therapy for the...
Press Releases
Novo Nordisk records for regulatory approval of long-acting factor VIII (N8-GP) in the US and the EU for treatment of haemophilia A
Novo Nordisk announced the submission of a Biologics License Applications (BLA) to the US FDA and a Marketing Authorisation Application (MAA) to the European Medicines...
Press Releases
Biogen, AbbVie draw Multiple Sclerosis Drug On Inflammation Reports
RBC analyst Brian Abrahams said the decision will have "zero material impact" on Biogen as Zinbryta was expected to bring in about $400 million in...
Press Releases
Pfizer gets optimistic response from CHMP for its CHEMOTHERAPY and MYELOGENOUS LEUKEMIA
Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted positive opinions recommending that two Pfizer hematology...
Press Releases
Elsevier collaborates with Beijing University of Chinese Medicine to enable deeper research into traditional Chinese medicine
As global interest in traditional and alternative medicine grows, Elsevier, the global information analytics business specializing in science and health, announced that it is working...
Press Releases
Enhanced ICP-MS Triple Quadrupole Technology for Ultra-trace Analysis
Semiconductor wafer fabrication plants and ultra-high purity chemical suppliers can now strengthen their monitoring of trace elements within challenging sample matrices with a new triple...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.